Suchergebnisse - "Hasford, J"

PubPharm (229)

1

A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues

enthalten in: European journal of clinical pharmacology | 2021

von Hasford, J. | Bruchmann, F. | Lutz, M. | +2

2

A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues

enthalten in: European journal of clinical pharmacology | 2021

von Hasford, J. | Bruchmann, F. | Lutz, M. | +2

3

A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues

enthalten in: European journal of clinical pharmacology | 2021

von Hasford, J. | Bruchmann, F. | Lutz, M. | +2

4

A patient-centred web-based adverse drug reaction reporting system identifies not yet labelled potential safety issues

enthalten in: European journal of clinical pharmacology | 2021

von Hasford, J. | Bruchmann, F. | Lutz, M. | +2

5

Preventable ADRs leading to hospitalization - results of a long-term prospective safety study with 6,427 ADR cases focusing on elderly patients

enthalten in: Expert opinion on drug safety | 2018

von Schmiedl, S. | Rottenkolber, M. | Szymanski, J. | +8

6

Assessment of imatinib as first-line treatment of chronic myeloid leukemia : 10-year survival results of the randomized CML study IV and impact of non-CML determinants

enthalten in: Leukemia | 2017

von Hehlmann, R. | Lauseker, M. | Saußele, S. | +67

CommentIn: Haematologica. 2019 May;104(5):862-864. - PMID 31040230

7

Treatment and outcome of 2904 CML patients from the EUTOS population-based registry

enthalten in: Leukemia | 2017

von Hoffmann, V. | Baccarani, M. | Hasford, J. | +30

8

A methodological comparison of two European primary care databases and replication in a US claims database : inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction

enthalten in: European journal of clinical pharmacology | 2016

von Afonso, A. | Schmiedl, S. | Becker, C. | +12

9

Secondary malignancies in chronic myeloid leukemia patients after imatinib-based treatment : long-term observation in CML Study IV

enthalten in: Leukemia | 2016

von Miranda, M. | Lauseker, M. | Kraus, M. | +26

10

A methodological comparison of two European primary care databases and replication in a US claims database: inhaled long-acting beta-2-agonists and the risk of acute myocardial infarction

enthalten in: European journal of clinical pharmacology | 2016

von Afonso, A. | Schmiedl, S. | Becker, C. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[23]